1. Home
  2. Live Updates
  3. Brian skorney

Live Breaking News & Updates on Brian skorney

Stay informed with the latest breaking news from Brian skorney on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Brian skorney and stay connected to the pulse of your community

Sarepta Therapeutics (SRPT) Q4 2023 Earnings Call Transcript

SRPT earnings call for the period ending December 31, 2023.

United-states , Kristen-kluska , Danielle-brill , Gil-blum-needham , Tazeen-ahmad , Brian-skorney , David-hoang , Gil-blum , Gena-wang , William-blair , Kostas-biliouris , David-hoang-citi

REGENXBIO Inc. (NASDAQ:RGNX) Q4 2023 Earnings Call Transcript

REGENXBIO Inc. misses on earnings expectations. Reported EPS is $-1.43 EPS, expectations were $-1.27. REGENXBIO Inc.

Orlando , Florida , United-states , Japan , Hawaii , America , Hawaiian , Annabel-samimy , Gena-wang , Danielle-brill , Lisa-walter , Vikram-purohit

Obesity drug mania takes over Amgen's earnings call

BioPharma

Novo-wegovy , Jay-bradner , Lilly-zepbound , Eli-lilly , Brian-skorney , Jefferie-michael-yee , Salim-syed , Amgen , Pfizer , Astrazeneca , Boehringer-ingelheim , Novo-nordisk

Oncologists Defend CAR-T After FDA Advisory

The agency is investigating reports of secondary blood cancers in patients who have received certain CAR T cell therapies, but experts say the risk is low and is outweighed by the terminal nature of some cancers.

United-states , San-diego , California , American , William-blair , Brian-skorney , Bruce-levine , Jack-allen , Rahul-banerjee , Bristol-myers-squibb , Meletios-verras , American-society-of-hematology

Regeneron, Sanofi to seek new Dupixent approval in US after COPD success

BioPharma

Brian-skorney , Drug-administration , European-medicines-agency , Regeneron-pharmaceuticals , Dive-brief , European-medicines , Clinical-trials ,

Sarepta Therapeutics (SRPT) Q3 2023 Earnings Call Transcript

SRPT earnings call for the period ending September 30, 2023.

United-states , Colin-bristow , Salveen-richter , Mike-hall-morgan-stanley , Brian-skorney , Gil-blum , Anupam-rama , Danielle-brill-raymond-james , Francesca-nolan , Joseph-schwartz-leerink , Brian-abrahams , Nicole-verdun

Opinion: These 3 healthcare stocks should come to life as boomers live their golden years

The baby-boom generation changes every aspect of life it steamrolls through. Now it’s doing the same to healthcare.

Karen-andersen , Zimmer-biomet , Brian-skorney , Damien-conover , Ivan-tornos , Tom-frinzi , Astrazeneca , Brookings-institute , Inflation-reduction-act , Federal-trade-commission , Morningstar-direct

Up 970-Fold Since Its IPO, Amgen Stock Could Be Overvalued

Amgen’s established products declined while some of its best-selling drugs enjoyed growth.

Amjevita-amgevita , Brian-skorney , Robert-bradway , David-risinger , Salveen-richter , Karen-andersen , Bristol-myers-squibb , Google , Drug-administration , Supreme-court , Goldman-sachs , Revenue-service

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Q2 2023 Earnings Call Transcript

Operator: Good afternoon, and thank you all for joining. I would like to welcome you all to the Mirum Pharmaceuticals Report Second Quarter 2023 Financial Results and Provide Business Update.

Canada , France , United-states , Germany , Steve-seedhouse , Andrew-mckibben , Thomas-yip , Peter-radovich , Brian-skorney , Mani-foroohar , David-lebowitz , Chris-peetz

Biogen, Sage face uphill battle with postpartum depression pill

The U.S. drug regulator's approval of
Biogen and Sage Therapeutics'
first-of-its-kind postpartum depression pill is unlikely
to allay the drugmakers' growth concerns, analysts said on
Monday.
...

Bengaluru , Karnataka , India , Brian-skorney , Manas-mishra , Bhanvi-satija , Christopher-viehbacher , Vinay-dwivedi , Michael-yee , Reuters , Drug-administration , Sage-therapeutic